What is LIFELOC TECHNOLOGIES INC's earnings per share (EPS)?

LIFELOC TECHNOLOGIES INC (LCTC) reported diluted earnings per share of -$0.90 for fiscal year 2025. This represents a -119.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

LIFELOC TECHNOLOGIES INC (LCTC) Financials

LCTC

Trailing 12 months to June 30, 2026

Revenue $9.3M +9.1% YoY

Net Income -$2.1M -78.9% YoY

EPS (Diluted) -$0.76 -81.0% YoY

Free Cash Flow -$835K +34.6% YoY

Market Cap $11.0M as of Oct 9, 2026

Price / Sales 1.2x on $9.3M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 2.9x on $3.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LCTC SEC filings page.

LIFELOC TECHNOLOGIES INC (LCTC) reported $9.3M in revenue over the twelve months to Jun 30, 2026, up 9.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LCTC FY2025 2026-10-03

The business keeps gross margins near 40.4%, but rising development costs and weak cash conversion leave losses despite modest revenue recovery.

Revenue recovered in FY2025 without restoring operating performance: gross margin was 40.4%, but operating margin was -13.6%, placing the pressure below production costs. R&D plus SG&A rose from $3.0M in FY2023 to $3.5M in FY2025, consistent with expense intensity—not volume alone—driving the weaker result.

FY2025's net loss was $2.5M, while operating cash outflow was $499K; the gap means the bottom line was materially shaped by non-cash or non-operating items, not just cash costs. Earnings therefore do not track cash generation cleanly.

Short-term coverage remained high while total assets fell from $8.7M in FY2024 to $6.7M in FY2025. Liabilities rose slightly to $2.6M as equity fell to $4.1M, so the balance sheet is less cushioned even though current obligations remain covered.

Financial Health Signals

Financial health score not available

LIFELOC TECHNOLOGIES INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Safe

3.53

LIFELOC TECHNOLOGIES INC scores 3.53, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($11.0M) relative to total liabilities ($2.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

2/9

LIFELOC TECHNOLOGIES INC passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

LIFELOC TECHNOLOGIES INC reported a net loss of $2.5M while operations used $499K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

LIFELOC TECHNOLOGIES INC reported an operating loss of $1.2M against $119K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.4M

YoY+10.2%

QoQ+6.6%

5Y CAGR+7.2%

10Y CAGR+0.7%

LIFELOC TECHNOLOGIES INC generated $2.4M in revenue in Q2 2026. This represents an increase of 10.2% from the same quarter a year earlier. Against the prior quarter it is up 6.6%.

EBITDA

-$35K

YoY+86.6%

QoQ+41.2%

LIFELOC TECHNOLOGIES INC's EBITDA was -$35K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 86.6% from the same quarter a year earlier. Against the prior quarter it is up 41.2%.

Net Income

-$134K

YoY+65.9%

QoQ+12.0%

LIFELOC TECHNOLOGIES INC reported -$134K in net income in Q2 2026. This represents an increase of 65.9% from the same quarter a year earlier. Against the prior quarter it is up 12.0%.

EPS (Diluted)

-$0.05

YoY+64.3%

QoQ+16.7%

LIFELOC TECHNOLOGIES INC earned -$0.05 per diluted share (EPS) in Q2 2026. This represents an increase of 64.3% from the same quarter a year earlier. Against the prior quarter it is up 16.7%.

Cash & Balance Sheet

Free Cash Flow

-$133K

YoY+54.8%

QoQ+1.1%

LIFELOC TECHNOLOGIES INC recorded an outflow of $133K in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 54.8% from the same quarter a year earlier. Against the prior quarter it is up 1.1%.

Cash & Debt

$908K

YoY-8.8%

QoQ+59.5%

5Y CAGR-17.6%

10Y CAGR-12.3%

LIFELOC TECHNOLOGIES INC held $908K in cash against $1.0M in long-term debt as of Q2 2026.

Shares Outstanding

YoY0.0%

QoQ0.0%

5Y CAGR+2.3%

10Y CAGR+1.2%

LIFELOC TECHNOLOGIES INC had 3M shares outstanding in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

44.7%

YoY+3.0pp

QoQ+1.6pp

5Y change+9.7pp

10Y change-7.8pp

LIFELOC TECHNOLOGIES INC's gross margin was 44.7% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.

Operating Margin

-4.2%

YoY+12.8pp

QoQ+1.3pp

LIFELOC TECHNOLOGIES INC's operating margin was -4.2% in Q2 2026, reflecting core business profitability. This is up 12.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.3 percentage points.

Net Margin

-5.5%

YoY+12.3pp

QoQ+1.2pp

5Y change+0.9pp

10Y change-12.7pp

LIFELOC TECHNOLOGIES INC's net profit margin was -5.5% in Q2 2026, showing the share of revenue converted to profit. This is up 12.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.

Return on Equity

-3.5%

YoY+3.2pp

QoQ+0.3pp

5Y change-1.8pp

10Y change-6.4pp

LIFELOC TECHNOLOGIES INC's ROE was -3.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 3.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Capital Allocation

R&D Spending

$560K

YoY-10.1%

QoQ+35.2%

LIFELOC TECHNOLOGIES INC invested $560K in research and development in Q2 2026. This represents a decrease of 10.1% from the same quarter a year earlier. Against the prior quarter it is up 35.2%.

Capital Expenditures

YoY-100.0%

QoQ-100.0%

LIFELOC TECHNOLOGIES INC reported no capital expenditure in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Share Buybacks

Not reported for Q2 2026.

LCTC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LCTC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$9.3M	$9.0M+5.7%	$8.5M-8.5%	$9.3M+10.0%	$8.5M+20.2%	$7.1M+11.0%	$6.4M-27.4%	$8.8M+3.7%	$8.4M+5.6%	$8.0M-4.7%	$8.4M-5.0%	$8.8M-5.5%	$9.3M+10.9%	$8.4M+23.2%	$6.8M-17.5%	$8.3M
Cost of Revenue	$5.4M	$5.4M+5.8%	$5.1M-3.7%	$5.3M-2.2%	$5.4M+35.4%	$4.0M-4.4%	$4.2M-13.3%	$4.8M+4.0%	$4.6M+8.2%	$4.3M+1.8%	$4.2M-5.0%	$4.4M-9.2%	$4.9M+11.3%	$4.4M+19.0%	$3.7M-18.8%	$4.5M
Gross Profit	$3.9M	$3.6M+5.7%	$3.4M-14.7%	$4.0M+31.4%	$3.1M+0.5%	$3.1M+40.3%	$2.2M-44.6%	$3.9M+3.3%	$3.8M+2.6%	$3.7M-11.1%	$4.2M-5.1%	$4.4M-1.5%	$4.5M+10.4%	$4.0M+28.2%	$3.2M-15.9%	$3.8M
R&D Expenses	$2.0M	$2.2M-4.0%	$2.2M+22.2%	$1.8M+32.4%	$1.4M+14.2%	$1.2M+20.5%	$1.0M-3.0%	$1.0M-7.5%	$1.1M+4.2%	$1.1M+3.8%	$1.0M-15.3%	$1.2M+22.4%	$1.0M+7.6%	$930K+77.7%	$523K+18.7%	$441K
SG&A Expenses	$1.4M	$1.4M+10.8%	$1.3M+7.1%	$1.2M-3.8%	$1.2M+9.5%	$1.1M-11.4%	$1.3M+6.7%	$1.2M+0.9%	$1.2M+4.6%	$1.1M-2.9%	$1.1M-9.5%	$1.3M+2.3%	$1.2M-3.5%	$1.3M+18.7%	$1.1M+4.2%	$1.0M
Operating Income	-$803K	-$1.2M+12.7%	-$1.4M-636.8%	-$191K+70.6%	-$650K-141.8%	-$269K+76.7%	-$1.2M-340.1%	$481K+77.8%	$271K+104.0%	$133K-79.1%	$635K+43.6%	$442K-44.3%	$795K+16.5%	$682K-2.2%	$697K-42.0%	$1.2M
EBITDA	N/A	-$787K+29.4%	-$1.1M-1612.0%	$74K+511.1%	-$18K-27.2%	-$14K+98.2%	-$791K-188.5%	$894K+30.0%	$688K+63.4%	$421K-54.2%	$918K+25.0%	$735K-26.5%	$1000K+13.5%	$881K+0.5%	$877K-34.4%	$1.3M
Interest Expense	$139K	$119K+196.9%	$40K-3.4%	$42K-3.5%	$43K-16.0%	$51K-8.7%	$56K-2.9%	$58K-6.2%	$62K+1.6%	$61K-8.0%	$66K-7.1%	$71K+495.9%	$12K	$0+100.0%	-$12K	$0
Income Tax	$1.2M	$1.2M+428.8%	-$353K+4.3%	-$368K-214.8%	-$117K-107.8%	-$56K+79.6%	-$275K-547.6%	$62K+253.0%	$17K-72.8%	$64K-58.2%	$154K+32.8%	$116K-45.9%	$214K+54.6%	$138K-43.9%	$247K-43.5%	$437K
Net Income	-$2.1M	-$2.5M-134.6%	-$1.1M-612.1%	$206K+145.1%	-$456K-167.4%	$676K+173.3%	-$922K-247.3%	$626K+188.2%	$217K+1387.1%	$15K-96.6%	$433K+53.5%	$282K-53.3%	$605K+5.3%	$575K+20.0%	$479K-38.5%	$779K
EPS (Basic)	N/A	-$0.90-119.5%	-$0.41-612.5%	$0.08+142.1%	-$0.19-167.9%	$0.28+173.7%	-$0.38-246.2%	$0.26+188.9%	$0.09+800.0%	$0.01-94.4%	$0.18+50.0%	$0.12-52.0%	$0.25+4.2%	$0.24+20.0%	$0.20-37.5%	$0.32
EPS (Diluted)	-$0.76	-$0.90-119.5%	-$0.41-612.5%	$0.08+142.1%	-$0.19-170.4%	$0.27+171.1%	-$0.38-246.2%	$0.26+188.9%	$0.09	$0.01	$0.17+54.5%	$0.11-54.2%	$0.240.0%	$0.24+20.0%	$0.20-37.5%	$0.32
Diluted Shares (Avg)	N/A	3M+7.5%	3M+3.8%	2M0.0%	2M-2.6%	3M+2.6%	2M0.0%	2M-2.3%	3M	3M	3M+0.9%	3M+1.0%	2M+2.7%	2M-0.5%	2M+0.8%	2M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$2.4M+10.2%	$2.3M+0.7%	$2.3M+19.0%	$2.3M+8.2%	$2.2M-7.0%	$2.3M+5.7%	$1.9M-12.7%	$2.1M-22.6%
Cost of Revenue	$1.4M+4.5%	$1.3M-4.5%	$1.4M+13.8%	$1.4M+14.9%	$1.3M-7.1%	$1.4M+3.8%	$1.2M-3.4%	$1.2M-25.4%
Gross Profit	$1.1M+18.2%	$987K+8.6%	$902K+27.9%	$907K-0.6%	$925K-6.9%	$909K+8.8%	$705K-25.2%	$912K-18.5%
R&D Expenses	$560K-10.1%	$414K-11.8%	$601K+19.3%	$459K-12.0%	$623K-5.9%	$470K-15.5%	$504K-4.3%	$521K+1.0%
SG&A Expenses	$315K-7.4%	$387K+0.7%	$323K+5.4%	$341K+26.4%	$340K-6.3%	$385K+22.2%	$306K+2.8%	$269K-0.1%
Operating Income	-$104K+72.6%	-$128K+54.4%	-$337K+20.3%	-$234K-12.5%	-$378K+4.7%	-$281K+26.2%	-$423K-102.1%	-$208K-978.0%
EBITDA	-$35K+86.6%	-$60K+66.2%	-$219K+32.1%	-$126K+3.2%	-$264K+20.8%	-$178K+45.9%	-$322K-125.3%	-$130K-244.1%
Interest Expense	$40K+50.6%	$31K+27.5%	$31K+216.9%	$37K+268.8%	$26K+161.6%	$24K+141.3%	$10K-3.2%	$10K-4.5%
Income Tax	$0	$0	$1.2M+1128.5%	$0+100.0%	$0+100.0%	$0+100.0%	-$113K+61.2%	-$50K+35.8%
Net Income	-$134K+65.9%	-$153K+47.8%	-$1.5M-386.1%	-$263K-66.4%	-$394K-32.1%	-$293K-3.1%	-$313K-430.5%	-$158K-244.5%
EPS (Basic)	-$0.05+64.3%	-$0.06+45.5%	-$0.55-400.0%	-$0.10-66.7%	-$0.14-16.7%	-$0.11+8.3%	-$0.11-466.7%	-$0.06-250.0%
EPS (Diluted)	-$0.05+64.3%	-$0.06+45.5%	-$0.55-400.0%	-$0.10-66.7%	-$0.14-16.7%	-$0.11+8.3%	-$0.11-466.7%	-$0.06-250.0%
Diluted Shares (Avg)	3M0.0%	3M+2.2%	N/A	3M+5.4%	3M+12.2%	3M+9.8%	N/A	3M+6.4%

LCTC Balance Sheet

LCTC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$6.7M-23.4%	$8.7M+0.4%	$8.7M+2.0%	$8.5M-4.8%	$8.9M+4.8%	$8.5M-5.4%	$9.0M+9.0%	$8.3M+2.3%	$8.1M+0.2%	$8.1M+4.9%	$7.7M+1.7%	$7.6M+46.6%	$5.2M+20.1%	$4.3M+10.9%	$3.9M
Current Assets	$4.3M-16.2%	$5.1M-10.8%	$5.7M-2.9%	$5.9M+0.3%	$5.9M+6.2%	$5.5M-5.5%	$5.8M+19.7%	$4.9M+6.5%	$4.6M-13.1%	$5.3M+8.6%	$4.9M+1.0%	$4.8M-0.1%	$4.8M+22.9%	$3.9M+12.4%	$3.5M
Cash & Equivalents	$746K-40.0%	$1.2M-29.6%	$1.8M-24.9%	$2.4M-8.5%	$2.6M+17.2%	$2.2M-31.1%	$3.2M+14.3%	$2.8M+4.5%	$2.7M-29.2%	$3.8M+16.9%	$3.2M+17.4%	$2.7M-18.1%	$3.4M+43.6%	$2.3M+26.7%	$1.8M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$2.6M-12.1%	$3.0M-0.9%	$3.0M+10.7%	$2.7M+2.4%	$2.7M+6.8%	$2.5M+25.8%	$2.0M+53.9%	$1.3M+9.8%	$1.2M+40.6%	$836K+4.2%	$802K-15.2%	$945K+28.3%	$737K-11.5%	$833K-20.5%	$1.0M
Accounts Receivable	$772K+5.4%	$733K-9.8%	$812K+29.3%	$628K+11.7%	$562K+7.4%	$524K-18.3%	$641K-5.0%	$675K+13.8%	$593K+19.8%	$495K-18.0%	$604K-29.4%	$855K+100.7%	$426K+5.2%	$405K-9.9%	$450K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$2.6M+3.4%	$2.5M+7.2%	$2.3M-1.3%	$2.4M+0.3%	$2.4M-10.6%	$2.6M+18.1%	$2.2M+5.4%	$2.1M-2.1%	$2.2M-0.9%	$2.2M-3.4%	$2.3M-7.0%	$2.4M+218.6%	$764K+39.2%	$549K-9.6%	$607K
Current Liabilities	$837K+12.5%	$744K-35.3%	$1.1M+1.1%	$1.1M+5.0%	$1.1M-20.1%	$1.4M+50.2%	$902K+21.7%	$741K-0.5%	$745K+3.4%	$721K-3.8%	$749K-14.1%	$873K+16.2%	$751K+38.3%	$543K-9.5%	$600K
Non-Current Liabilities	$1.7M-0.5%	$1.8M+48.5%	$1.2M-3.6%	$1.2M-3.8%	$1.3M-0.5%	$1.3M-3.7%	$1.3M-3.4%	$1.4M-3.0%	$1.4M-3.0%	$1.5M-3.2%	$1.5M-3.0%	$1.6M+12347.3%	$13K+125.4%	$6K-11.3%	$6K
Long-Term Debt	$1.1M-5.4%	$1.1M-4.4%	$1.2M-4.1%	$1.2M-3.8%	$1.3M-0.8%	$1.3M-3.5%	$1.3M-3.3%	$1.4M-2.9%	$1.4M-3.1%	$1.5M-2.6%	$1.5M-3.0%	$1.5M	$0	N/A	N/A
Total Equity	$4.1M-34.1%	$6.2M-2.1%	$6.4M+3.3%	$6.2M-6.7%	$6.6M+11.7%	$5.9M-13.1%	$6.8M+10.3%	$6.2M+4.0%	$5.9M+0.6%	$5.9M+8.4%	$5.4M+5.8%	$5.1M+16.8%	$4.4M+17.4%	$3.7M+14.7%	$3.3M
Retained Earnings	-$1.8M-386.1%	$640K-62.2%	$1.7M+13.8%	$1.5M-23.5%	$1.9M+53.4%	$1.3M-42.1%	$2.2M+40.0%	$1.6M+16.1%	$1.3M+1.1%	$1.3M+48.2%	$898K+45.8%	$616K+5538.7%	$11K+101.9%	-$564K+45.9%	-$1.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$7.1M-17.9%	$6.7M-26.9%	$6.7M-23.4%	$8.3M-0.5%	$8.6M+7.6%	$9.2M+10.7%	$8.7M+0.4%	$8.3M-3.0%
Current Assets	$4.8M-3.8%	$4.4M-23.0%	$4.3M-16.2%	$4.6M-3.2%	$5.0M+10.0%	$5.7M+11.9%	$5.1M-10.8%	$4.8M-20.9%
Cash & Equivalents	$908K-8.8%	$569K-62.6%	$746K-40.0%	$685K-18.6%	$996K+97.3%	$1.5M+47.6%	$1.2M-29.6%	$842K-60.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$2.8M-5.0%	$2.8M-5.0%	$2.6M-12.1%	$2.9M-9.4%	$3.0M+0.9%	$2.9M-2.5%	$3.0M-0.9%	$3.2M+8.5%
Accounts Receivable	$827K+8.0%	$850K+11.6%	$772K+5.4%	$864K+41.4%	$766K-7.9%	$762K+0.6%	$733K-9.8%	$611K-13.8%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$3.3M+19.3%	$2.8M-5.1%	$2.6M+3.4%	$2.7M+39.1%	$2.7M+22.5%	$2.9M+30.5%	$2.5M+7.2%	$1.9M-17.7%
Current Liabilities	$1.1M+14.9%	$1.1M-6.1%	$837K+12.5%	$908K+15.8%	$956K-11.6%	$1.1M+4.5%	$744K-35.3%	$784K-31.4%
Non-Current Liabilities	$2.2M+21.6%	$1.7M-4.4%	$1.7M-0.5%	$1.8M+55.1%	$1.8M+54.6%	$1.8M+54.6%	$1.8M+48.5%	$1.1M-4.6%
Long-Term Debt	$1.0M-5.1%	$1.0M-5.0%	$1.1M-5.4%	$1.1M-5.3%	$1.1M-5.1%	$1.1M-5.0%	$1.1M-4.4%	$1.1M-4.3%
Total Equity	$3.8M-35.2%	$4.0M-37.1%	$4.1M-34.1%	$5.6M-12.4%	$5.9M+1.9%	$6.3M+3.4%	$6.2M-2.1%	$6.4M+2.4%
Retained Earnings	-$2.1M-4457.7%	-$2.0M-671.3%	-$1.8M-386.1%	-$310K-132.5%	-$46K-104.2%	$347K-75.4%	$640K-62.2%	$953K-40.4%

Not reported in any period shown, so not listed: Goodwill.

LCTC Cash Flow Statement

LCTC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$372K	-$499K+62.4%	-$1.3M-152.5%	-$526K-1067.8%	$54K-70.3%	$183K+113.4%	-$1.4M-295.1%	$699K+22.5%	$570K+414.6%	-$181K-128.7%	$631K-32.0%	$929K+285.0%	$241K-80.1%	$1.2M+91.3%	$634K+16.7%	$543K
Depreciation & Amortization	N/A	$443K+50.8%	$294K+11.0%	$265K-58.1%	$632K+148.2%	$255K-30.1%	$364K-11.7%	$413K-1.0%	$417K+44.7%	$288K+1.7%	$283K-3.2%	$293K+42.7%	$205K+3.1%	$199K+11.0%	$179K+33.3%	$135K
Stock-Based Compensation	N/A	N/A	N/A	$0-100.0%	$17K+0.3%	$17K-43.5%	$30K+436.4%	$6K-67.6%	$17K-23.6%	$23K-6.0%	$24K	$0	$0-100.0%	$60K	$0-100.0%	$32K
Capital Expenditures	$463K	$463K-14.3%	$540K+7824.4%	$7K-96.8%	$213K-19.8%	$266K+867.6%	$27K-89.3%	$257K-36.1%	$402K+3294.8%	$12K-72.3%	$43K-89.4%	$403K+204.1%	$132K-24.9%	$176K+25.5%	$141K+4.1%	$135K
Free Cash Flow	-$835K	-$962K+48.5%	-$1.9M-250.7%	-$533K-235.2%	-$159K-91.6%	-$83K+94.0%	-$1.4M-414.8%	$442K+162.8%	$168K+187.1%	-$193K-132.8%	$588K+11.9%	$526K+383.6%	$109K-89.5%	$1.0M+110.0%	$493K+20.9%	$408K
Investing Cash Flow	-$132K	-$354K+48.6%	-$689K-8292.5%	-$8K+96.3%	-$223K+17.1%	-$268K-480.2%	-$46K+82.0%	-$257K+37.2%	-$409K+53.4%	-$877K-1594.8%	-$52K+88.0%	-$431K+48.9%	-$844K-305.5%	-$208K-48.0%	-$141K+12.2%	-$160K
Financing Cash Flow	$417K	$356K-76.2%	$1.5M+2963.8%	-$52K-3.0%	-$51K-111.0%	$462K+10.3%	$419K+1046.3%	-$44K-4.1%	-$43K+3.5%	-$44K-27.2%	-$35K-75.8%	-$20K-258.6%	-$5K-136.2%	$15K	N/A	$0

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$133K+53.9%	-$129K-28.9%	$79K+127.1%	-$189K+39.8%	-$289K-258.6%	-$100K+84.4%	-$292K+21.5%	-$314K-229.0%
Depreciation & Amortization	$68K-40.2%	$68K-33.8%	$118K+17.3%	$109K+38.5%	$114K+79.5%	$102K+100.5%	$101K+52.1%	$78K+18.2%
Capital Expenditures	$0-100.0%	$5K	$423K+581.5%	$34K-84.1%	$5K-97.3%	$0-100.0%	$62K+319.6%	$214K+3042.4%
Free Cash Flow	-$133K+54.8%	-$135K-34.3%	-$344K+2.8%	-$223K+57.7%	-$295K-3.0%	-$100K+85.7%	-$354K+8.5%	-$527K-323.1%
Investing Cash Flow	$0+100.0%	-$20K-6.6%	-$4K+90.1%	-$108K+19.4%	-$224K+48.3%	-$19K+76.9%	-$43K-387.2%	-$134K-1869.8%
Financing Cash Flow	$472K+3524.7%	-$28K-106.9%	-$14K-101.9%	-$14K-101.8%	-$14K-3.0%	$398K+3092.5%	$736K+5683.1%	$785K+6162.3%

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

LCTC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LCTC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	40.4%0.0pp	40.4%-2.9pp	43.3%+7.1pp	36.3%-7.1pp	43.4%+9.1pp	34.3%-10.7pp	45.0%-0.2pp	45.1%-1.3pp	46.5%-3.4pp	49.9%0.0pp	49.9%+2.0pp	47.8%-0.2pp	48.0%+1.9pp	46.2%+0.9pp	45.3%
Operating Margin	-13.6%+2.9pp	-16.5%-14.4pp	-2.1%+5.6pp	-7.7%-3.9pp	-3.8%+14.4pp	-18.2%-23.7pp	5.5%+2.3pp	3.2%+1.5pp	1.7%-5.9pp	7.6%+2.6pp	5.0%-3.5pp	8.5%+0.4pp	8.1%-2.1pp	10.2%-4.3pp	14.5%
Net Margin	-27.4%-15.0pp	-12.3%-14.5pp	2.2%+7.6pp	-5.4%-14.9pp	9.6%+24.1pp	-14.5%-21.6pp	7.1%+4.6pp	2.6%+2.4pp	0.2%-5.0pp	5.2%+2.0pp	3.2%-3.3pp	6.5%-0.3pp	6.8%-0.2pp	7.0%-2.4pp	9.4%
Return on Equity	-60.2%-43.3pp	-16.9%-20.1pp	3.2%+10.6pp	-7.4%-17.6pp	10.3%+25.9pp	-15.6%-24.8pp	9.2%+5.7pp	3.5%+3.3pp	0.3%-7.1pp	7.4%+2.2pp	5.2%-6.6pp	11.8%-1.3pp	13.1%+0.3pp	12.8%-11.0pp	23.8%
Return on Assets	-37.0%-24.9pp	-12.1%-14.4pp	2.4%+7.7pp	-5.3%-12.9pp	7.5%+18.4pp	-10.8%-17.7pp	6.9%+4.3pp	2.6%+2.4pp	0.2%-5.2pp	5.4%+1.7pp	3.7%-4.3pp	8.0%-3.1pp	11.1%0.0pp	11.2%-9.0pp	20.1%
Current Ratio	5.10-1.7x	6.85+1.9x	4.97-0.2x	5.17-0.2x	5.42+1.3x	4.07-2.4x	6.47-0.1x	6.58+0.4x	6.15-1.2x	7.31+0.8x	6.47+1.0x	5.50-0.9x	6.40-0.8x	7.20+1.4x	5.80
Debt-to-Equity	0.26+0.1x	0.180.0x	0.180.0x	0.200.0x	0.190.0x	0.220.0x	0.200.0x	0.220.0x	0.240.0x	0.250.0x	0.280.0x	0.30+0.3x	0.00-0.1x	0.150.0x	0.19
Asset Turnover	1.35+0.4x	0.98-0.1x	1.07+0.1x	1.00+0.2x	0.790.0x	0.74-0.2x	0.970.0x	1.020.0x	0.99-0.1x	1.04-0.1x	1.15-0.1x	1.23-0.4x	1.630.0x	1.59-0.5x	2.14
FCF Margin	-10.7%+11.2pp	-21.9%-16.2pp	-5.7%-3.8pp	-1.9%-0.7pp	-1.2%+20.7pp	-21.9%-26.9pp	5.1%+3.1pp	2.0%+4.4pp	-2.4%-9.4pp	7.0%+1.1pp	6.0%+4.8pp	1.2%-11.1pp	12.3%+5.1pp	7.2%+2.3pp	4.9%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	44.7%+3.0pp	43.0%+3.1pp	39.7%+2.8pp	40.2%-3.5pp	41.7%0.0pp	39.9%+1.1pp	36.9%-6.1pp	43.7%+2.2pp
Operating Margin	-4.2%+12.8pp	-5.6%+6.7pp	-14.8%+7.3pp	-10.4%-0.4pp	-17.0%-0.4pp	-12.3%+5.3pp	-22.1%-12.6pp	-10.0%-10.9pp
Net Margin	-5.5%+12.3pp	-6.7%+6.2pp	-66.9%-50.5pp	-11.7%-4.1pp	-17.7%-5.3pp	-12.8%+0.3pp	-16.4%-20.7pp	-7.6%-11.7pp
Return on Equity	-3.5%+3.2pp	-3.9%+0.8pp	-37.1%-32.0pp	-4.7%-2.2pp	-6.7%-1.5pp	-4.7%0.0pp	-5.0%-6.5pp	-2.5%-4.2pp
Return on Assets	-1.9%+2.7pp	-2.3%+0.9pp	-22.7%-19.1pp	-3.2%-1.3pp	-4.6%-0.8pp	-3.2%+0.2pp	-3.6%-4.7pp	-1.9%-3.2pp
Current Ratio	4.35-0.8x	4.11-0.9x	5.10-1.7x	5.08-1.0x	5.19+1.0x	5.01+0.3x	6.85+1.9x	6.08+0.8x
Debt-to-Equity	0.27+0.1x	0.26+0.1x	0.26+0.1x	0.190.0x	0.180.0x	0.180.0x	0.180.0x	0.180.0x
Asset Turnover	0.35+0.1x	0.34+0.1x	0.34+0.1x	0.270.0x	0.260.0x	0.250.0x	0.220.0x	0.25-0.1x
FCF Margin	-5.5%+7.8pp	-5.9%-1.5pp	-15.1%+3.4pp	-9.9%+15.4pp	-13.3%-1.3pp	-4.4%+28.1pp	-18.5%-0.9pp	-25.3%-34.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
LIFELOC TECHNOLOGIES INC LCTC	FY2025	$9.0M	-$2.5M	-27.4%	$11.0M	—
SCIENTIFIC INDUSTRIES INC SCND	FY2025	$5.1M	-$1.2M	-24.1%	$8.2M	—
GLOBAL WARMING SLTNS INC GWSO	FY2023	$0	-$516K	N/A	$1.5M	—
DARKPULSE INC DPLS	FY2025	$308K	-$3.0M	N/A	$906K	—

Where LIFELOC TECHNOLOGIES INC Ranks

Frequently Asked Questions

What is LIFELOC TECHNOLOGIES INC's annual revenue?

LIFELOC TECHNOLOGIES INC (LCTC) reported $9.0M in total revenue for fiscal year 2025. This represents a 5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is LIFELOC TECHNOLOGIES INC's revenue growing?

LIFELOC TECHNOLOGIES INC (LCTC) revenue grew by 5.7% year-over-year, from $8.5M to $9.0M in fiscal year 2025.

Is LIFELOC TECHNOLOGIES INC profitable?

No, LIFELOC TECHNOLOGIES INC (LCTC) reported a net income of -$2.5M in fiscal year 2025, with a net profit margin of -27.4%.

What is LIFELOC TECHNOLOGIES INC's EBITDA?

LIFELOC TECHNOLOGIES INC (LCTC) had EBITDA of -$787K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does LIFELOC TECHNOLOGIES INC have?

As of fiscal year 2025, LIFELOC TECHNOLOGIES INC (LCTC) had $746K in cash and equivalents against $1.1M in long-term debt.

What is LIFELOC TECHNOLOGIES INC's gross margin?

LIFELOC TECHNOLOGIES INC (LCTC) had a gross margin of 40.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is LIFELOC TECHNOLOGIES INC's operating margin?

LIFELOC TECHNOLOGIES INC (LCTC) had an operating margin of -13.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is LIFELOC TECHNOLOGIES INC's net profit margin?

LIFELOC TECHNOLOGIES INC (LCTC) had a net profit margin of -27.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is LIFELOC TECHNOLOGIES INC's return on equity (ROE)?

LIFELOC TECHNOLOGIES INC (LCTC) has a return on equity of -60.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is LIFELOC TECHNOLOGIES INC's free cash flow?

LIFELOC TECHNOLOGIES INC (LCTC) recorded an outflow of $962K in free cash flow during fiscal year 2025. This represents a 48.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is LIFELOC TECHNOLOGIES INC's operating cash flow?

LIFELOC TECHNOLOGIES INC (LCTC) recorded an outflow of $499K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are LIFELOC TECHNOLOGIES INC's total assets?

LIFELOC TECHNOLOGIES INC (LCTC) had $6.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are LIFELOC TECHNOLOGIES INC's capital expenditures?

LIFELOC TECHNOLOGIES INC (LCTC) invested $463K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does LIFELOC TECHNOLOGIES INC spend on research and development?

LIFELOC TECHNOLOGIES INC (LCTC) invested $2.2M in research and development during fiscal year 2025.

How many shares does LIFELOC TECHNOLOGIES INC have outstanding?

LIFELOC TECHNOLOGIES INC (LCTC) had 3M shares outstanding as of fiscal year 2025.

What is LIFELOC TECHNOLOGIES INC's current ratio?

LIFELOC TECHNOLOGIES INC (LCTC) had a current ratio of 5.10 as of fiscal year 2025, which is generally considered healthy.

What is LIFELOC TECHNOLOGIES INC's debt-to-equity ratio?

LIFELOC TECHNOLOGIES INC (LCTC) had a debt-to-equity ratio of 0.26 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is LIFELOC TECHNOLOGIES INC's return on assets (ROA)?

LIFELOC TECHNOLOGIES INC (LCTC) had a return on assets of -37.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is LIFELOC TECHNOLOGIES INC's P/E ratio?

LIFELOC TECHNOLOGIES INC (LCTC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $11.0M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is LIFELOC TECHNOLOGIES INC's price-to-sales ratio?

LIFELOC TECHNOLOGIES INC (LCTC) trades at 1.2x sales, its market capitalization divided by revenue of $9.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $11.0M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does LIFELOC TECHNOLOGIES INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, LIFELOC TECHNOLOGIES INC (LCTC) held $746K in cash, cash equivalents and investments, and reported an operating cash outflow of $499K over that year. Dividing the one by the other, the reported balance equals about 18 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is LIFELOC TECHNOLOGIES INC's Altman Z-Score?

LIFELOC TECHNOLOGIES INC (LCTC) has an Altman Z-Score of 3.53, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is LIFELOC TECHNOLOGIES INC's Piotroski F-Score?

LIFELOC TECHNOLOGIES INC (LCTC) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are LIFELOC TECHNOLOGIES INC's earnings high quality?

LIFELOC TECHNOLOGIES INC (LCTC) reported a net loss of $2.5M while operations used $499K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can LIFELOC TECHNOLOGIES INC cover its interest payments?

LIFELOC TECHNOLOGIES INC (LCTC) reported an operating loss of $1.2M against $119K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.